Back to search

Article

Engineering novel AAV capsids by global de-targeting and subsequent muscle-specific tropism in mice and NHPs

2025-05-19

Abstract excerpt

Recombinant adeno-associated viral (rAAV) vectors are a potent tool, but their clinical application is restricted by insufficient target tissue transduction and liver toxicity. We employed a novel two-step engineering strategy to create novel rAAV capsids with global tissue de-targeting, then produced strong tissue-specific expression by adding a peptide sequence. We created a novel capsid, AAV.Zero1, with globall...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69105701-a2c0-518f-86ba-533cfd9d30fe
DOI
10.1101/2025.05.19.654800
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Engineering novel AAV capsids by global de-targeting and subsequent muscle-specific tropism in mice and NHPsDOI 10.1101/2025.05.19.654800
Select a neighboring publication to make it the new centre.